Skip to content

Rehabilitation effect and safety of Novel Plum blossom moxa needle combined with channel palpation method for patients of stage I of shoulder hand syndrome (SHS) after cerebral stroke

Rehabilitation effect and safety of Novel Plum blossom moxa needle combined with channel palpation method for patients of stage I of shoulder hand syndrome (SHS) after cerebral stroke

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200065558
Enrollment
Unknown
Registered
2022-11-08
Start date
2022-11-30
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder hand syndrome (SHS) after stroke

Interventions

Sponsors

Beijing Huguosi Traditional Chinese Medicine Hospital, affiliated to Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Conformed by the diagnostic standards of Western medicine for cerebral stroke; 2. conformed by the diagnostic standards of SHS stage I; 3. cerebrovascular diseases confirmed by imaging (including but not limited to head CT or MRI); ischemic stroke within two times, and the treatment time after the onset is between two weeks and three months; 4. the gender unlimited; 5. the age between 50-76 years old; 6. the patient's vital signs are stable, and they volunteer to participate in and actively cooperate to complete the project; 7. they are full awareness of study and sign the consent form.

Exclusion criteria

Exclusion criteria: 1. Cerebrovascular diseases other than stroke; 2. patients with abnormal pain threshold caused by lesions in thalamus; 3. patients with other serious internal diseases; 4. patients with serious emotional disorders after stroke; 5. patients with dislocation and subluxation of shoulder joint; 6. patients with peri-arthritis of shoulder and local soft tissue injury with serious activities have been diagnosed before stroke; 7. intolerant of treatment.

Design outcomes

Primary

MeasureTime frame
VAS scores;Safety Observation;

Secondary

MeasureTime frame
Modified Barthel Index;Upper-extremety Fugl-Meyer Score;modified Ashworth scale;somatosensory evoked potential;

Countries

China

Contacts

Public ContactMeng Xiaonan

Beijing Huguosi Traditional Chinese Medicine Hospital, affiliated to Beijing University of Chinese Medicine

mengxiaonan.cn@gmail.com+86 13810988685

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026